An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

Clinical trial NCT04494412 · COMPLETED

Trial details

NCT number: NCT04494412
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human Arthralgia

Start date: 2022-11-21
Primary completion: 2026-01-14
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.